Vyepti vs. Aimovig
Are Vyepti and Aimovig the Same Thing?
Vyepti (eptinezumab-jjmr) and Aimovig (erenumab-aooe) are calcitonin gene-related peptide antagonists used to prevent migraine in adults.
Side effects of Vyepti that are different from Aimovig include runny or stuffy nose and hypersensitivity reactions (itching, flushing).
Side effects of Aimovig Aimovig that are different from Vyepti include injection site reactions (pain or redness), constipation, and muscle spasms or cramps.
Both Vyepti and may interact with other drugs.
What Are Possible Side Effects of Vyepti?
Side effects of Vyepti include:
- runny or stuffy nose and
- hypersensitivity reactions (itching, flushing)
What Are Possible Side Effects of Aimovig?
Common side effects of Aimovig include:
- injection site reactions (pain or redness),
- constipation, and
- muscle spasms or
- cramps
What Is Vyepti?
Vyepti (eptinezumab-jjmr) is a calcitonin gene-related peptide antagonist indicated for the preventive treatment of migraine in adults.
What Is Aimovig?
Aimovig (erenumab-aooe) Injection is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.
What Drugs Interact With Vyepti?
Vyepti may interact with other medicines.
Tell your doctor all medications and supplements you use.
What Drugs Interact With Aimovig?
Aimovig may interact with other drugs. Tell your doctor all medications and supplements you use.
How Should Vyepti be Taken?
The recommended dosage of Vyepti is 100 mg as an intravenous infusion over approximately 30 minutes every 3 months. Some patients may benefit from a dosage of 300 mg.
How Should Aimovig be Taken?
The recommended dosage of Aimovig is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly, which is administered as two consecutive subcutaneous injections of 70 mg each.